Literature DB >> 7380548

Chemotaxigenesis by encapsulated Staphylococcus aureus M.

D J Schmeling, P K Peterson, I M Barr, Y Kim, P G Quie.   

Abstract

Although encapsulated Staphylococcus aureus M is not opsonized by normal human serum, as a chemotaxigen this organism behaved similarly to an unencapsulated variant strain. For optimal chemotaxigenesis, an intact classical complement pathway was required, and C5a appeared to be the major chemotaxin.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7380548      PMCID： PMC550823          DOI： 10.1128/iai.27.2.700-703.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  Pathology of chemotaxis and random mobility.

Authors:  M E Miller
Journal:  Semin Hematol       Date:  1975-01       Impact factor: 3.851

2.  Kinetic analysis of chemotactic factor generation in human serum via activation of the classical and alternate complement pathways.

Authors:  J I Gallin; R A Clark; M M Frank
Journal:  Clin Immunol Immunopathol       Date:  1975-01

3.  Inherited deficiency of the second component of complement (C2) with membranoproliferative glomerulonephritis.

Authors:  Y Kim; P S Friend; I G Dresner; E J Yunis; A F Michael
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

4.  Chemotactic factor influences on the aggregation, swelling, and foreign surface adhesiveness of human leukocytes.

Authors:  J T O'Flaherty; D L Kreutzer; P A Ward
Journal:  Am J Pathol       Date:  1978-03       Impact factor: 4.307

5.  Induction of leukochemotaxis by peptidoglycan of Staphylococcus aureus.

Authors:  A Grov; K Sveen
Journal:  Acta Pathol Microbiol Scand B       Date:  1978-12

6.  Studies of the alternate pathway in chelated serum.

Authors:  A Forsgren; R H Mclean; A F Michael; P G Quie
Journal:  J Lab Clin Med       Date:  1975-06

7.  Chemotaxigenesis by cell surface components of Staphylococcus aureus.

Authors:  D J Schmeling; P K Peterson; D E Hammerschmidt; Y Kim; J Verhoef; B J Wilkinson; P G Quie
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

8.  Dichotomy between opsonization and serum complement activation by encapsulated staphylococci.

Authors:  P K Peterson; Y Kim; B J Wilkinson; D Schmeling; A F Michael; P G Quie
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

9.  Polymorphonuclear leukocyte chemotactic activity in rabbit serum and Guinea pig serum treated with immune complexes: evidence for c5a as the major chemotactic factor.

Authors:  R Snyderman; J Phillips; S E Mergenhagen
Journal:  Infect Immun       Date:  1970-06       Impact factor: 3.441

10.  Factors relating to the virulence of staphylococci. I. Comparative studies on two colonial variants.

Authors:  M G KOENIG
Journal:  Yale J Biol Med       Date:  1962-06
View more
  4 in total

1.  Effect of staphylococcal alpha-toxin on neutrophil migration and adhesiveness.

Authors:  D J Schmeling; C G Gemmell; P R Craddock; P G Quie; P K Peterson
Journal:  Inflammation       Date:  1981-12       Impact factor: 4.092

2.  Inflammatory and immunological responses in skin and peripheral lymph of sheep following intracutaneous injection of Staphylococcus aureus.

Authors:  R L Kerlin; D L Watson; I G Colditz
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

3.  Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors.

Authors:  D E Wexler; R D Nelson; P P Cleary
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement.

Authors:  M C Cerquetti; D O Sordelli; R A Ortegon; J A Bellanti
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.